Dihydroartemisinin-Loaded Chitosan Nanoparticles Inhibit the Rifampicin-Resistant Mycobacterium tuberculosis by Disrupting the Cell Wall

Dihydroartemisinin-Loaded Chitosan Nanoparticles Inhibit the Rifampicin-Resistant Mycobacterium tuberculosis by Disrupting the Cell Wall

Tuberculosis (TB) caused by Mycobacterium tuberculosis (MTB) is a deadly infection, and increasing resistance worsens an already bad scenario. In this work, a new nanomedicine antibacterial agent, based on dihydroartemisinin (DHA) and chitosan (CS), has been successfully developed to overcome MTB’s...

Full description

Bibliographic Details
Main Authors:	Xiujuan Gu, Qi Cheng, Ping He, Yan Zhang, Zhengfang Jiang, Yali Zeng
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-09-01
Series:	Frontiers in Microbiology
Subjects:	Mycobacterium tuberculosis rifampin-resistance dihydroartemisinin chitosan nanoparticle gas chromatography-mass spectrometry
Online Access:	https://www.frontiersin.org/articles/10.3389/fmicb.2021.735166/full

Similar Items

The evaluation of the Xpert MTB/RIF in the diagnosis of mycobacterium tuberculosis complex and detection of rifampicin resistance in extrapulmonary (pleural and ascitic) fluid samples received for routine immunophenotypic analysis in a high-burden tuberculosis setting
by: Kilfoil, Kim Michelle
Published: (2016)

Evaluation of GeneXpert Mycobacterium tuberculosis/Rifampin for the detection of Mycobacterium tuberculosis complex and rifampicin resistance in nonrespiratory clinical specimens
by: Maya Habous, et al.
Published: (2019-01-01)

Interpreting very low Mycobacterium tuberculosis detected on Xpert Mycobacterium tuberculosis/rifampicin
by: Kanchan Ajbani, et al.
Published: (2019-01-01)

Detection of Rifampicin Resistance in Mycobacterium tuberculosis by Using Middlebrook 7H9 Broth Medium with 2,3-Diphenyl-5-Thienyl-(2)-Tetrazolium Chloride
by: Sun Min Lee, et al.
Published: (2018-09-01)

rpoB Mutations and Effects on Rifampin Resistance in Mycobacterium tuberculosis
by: Li M, et al.
Published: (2021-10-01)

Evidenziazione molecolare di resistenza di Mycobacterium tuberculosis complex a rifampicina e isoniazide
by: Gian Lorenzo Molinari, et al.
Published: (2006-06-01)

The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in <it>Mycobacterium tuberculosis</it>
by: Parsons Linda M, et al.
Published: (2001-04-01)

The solubility enhancement and the stability assessment of rifampicin, isoniazid and pyrazinamide in aqueous media
by: Chen, Yu-Jen
Published: (2000)

Altered Mycobacterium tuberculosis Cell Wall Metabolism and Physiology Associated With RpoB Mutation H526D
by: Victoria L. Campodónico, et al.
Published: (2018-03-01)

Identification of Mycobacterium tuberculosis and Rifampin Resistance in Pulmonary and Extra-pulmonary Clinical Specimens Using the Gene Xpert MTB/RIF Assay
by: Fahimeh Azadi, et al.
Published: (2021-07-01)

Multiple rpoB Mutants of Mycobacterium tuberculosis and Second-order Selection
by: Igor Mokrousov
Published: (2004-07-01)

Rifampicin-induced thrombocytopenia
by: Ramírez Quintero, Juan David, et al.
Published: (2018-01-01)

Molecular Identification of Mycobacterium tuberculosis and Analysis of Its Resistance to Rifampin in Sputa From Tuberculosis Suspected Patients
by: M. Syaifudin
Published: (2010-08-01)

Dihydroartemisinin Induces Growth Arrest and Overcomes Dexamethasone Resistance in Multiple Myeloma
by: Ying Chen, et al.
Published: (2020-05-01)

Formulation of Dihydroartemisinin-Piperaquine (DHP) Generic Tablet as Antimalarials Drug
by: Nanang Yunarto, et al.
Published: (2016-09-01)

Corrigendum: Dihydroartemisinin Induces Growth Arrest and Overcomes Dexamethasone Resistance in Multiple Myeloma
by: Ying Chen, et al.
Published: (2021-07-01)

An investigation of the auto-induction of and gender-related variability in the pharmacokinetics of dihydroartemisinin in the rat
by: Zhu Fanping, et al.
Published: (2012-11-01)

Choreoathetosis – an unusual adverse effect of dihydroartemisinin-piperaquine: a case report
by: Benjamin Momo Kadia, et al.
Published: (2017-12-01)

Dihydroartemisinin inhibits TCTP-dependent metastasis in gallbladder cancer
by: Fei Zhang, et al.
Published: (2017-05-01)

Bioequivalence study of dihydroartemisinin-piperaquine (DHP) generic formulation in fixed-dose combination, in healthy Indonesian volunteers
by: Ani Isnawati, et al.
Published: (2018-08-01)

Mycobacterium kyorinense Infection
by: Hiroaki Ohnishi, et al.
Published: (2013-03-01)

Design, Synthesis, and Mechanism of Dihydroartemisinin–Coumarin Hybrids as Potential Anti-Neuroinflammatory Agents
by: Haonan Yu, et al.
Published: (2019-04-01)

Dihydroartemisinin as a Sensitizing Agent in Cancer Therapies
by: Li Q, et al.
Published: (2021-04-01)

Mutaciones asociadas con resistencia a rifampicina o isoniazida en aislamientos clínicos de M. tuberculosis de Sonora, México DNA mutations associated to rifampicin or isoniazid resistance in M. tuberculosis clinical isolates from Sonora, Mexico
by: Enrique Bolado-Martínez, et al.
Published: (2012-04-01)

Comparison Of drrA And drrB Efflux Pump Genes Expression In Drug-Susceptible And -Resistant Mycobacterium tuberculosis Strains Isolated From Tuberculosis Patients In Iran
by: Khosravi AD, et al.
Published: (2019-11-01)

Self-assembled dihydroartemisinin nanoparticles as a platform for cervical cancer chemotherapy
by: Yun Lu, et al.
Published: (2020-01-01)

Characteristics of infants exposed to maternal tuberculosis and chemoprophylaxis using three months of isoniazid and rifampicin
by: Mathivha, Khakhu Tshilidzi
Published: (2016)

Sub-minimum inhibitory concentration of rifampin: a potential risk factor for resuscitation of Mycobacterium tuberculosis
by: Shahin Pourazar Dizaji, et al.
Published: (2017-11-01)

Rapid prediction of multi-drug resistance in clinical specimens of Mycobacterium tuberculosis.
by: Ndimande, Bongiwe Olga.
Published: (2012)

The inhibitory effect of dihydroartemisinin on the growth of neuroblastoma cells
by: Ling Qi, et al.
Published: (2016-04-01)

Evaluation of usefulness of single-strand conformation polymorphism method for rapid detection of rifampicin-resistant mycobacterium tuberculosis
by: Tešić Jelena, et al.
Published: (2004-01-01)

A randomized trial of dihydroartemisinin–piperaquine versus artemether–lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Mali
by: Souleymane Dama, et al.
Published: (2018-10-01)

Dihydroartemisinin esters as prodrugs against resistant P. falciparum strains / Krebs J.H.
by: Krebs, Johann Hendrik
Published: (2012)

Dihydroartemisinin esters as prodrugs against resistant P. falciparum strains / Krebs J.H.
by: Krebs, Johann Hendrik
Published: (2012)

Dihydroartemisinin regulates apoptosis, migration, and invasion of ovarian cancer cells via mediating RECK
by: Jingfei Zheng, et al.
Published: (2021-06-01)

TMT-based proteomics analysis of the anti-hepatocellular carcinoma effect of combined dihydroartemisinin and sorafenib
by: Chunying Hou, et al.
Published: (2020-06-01)

Detection of rpoB, inhA and katG Genes Mutations in Clinical Isolates of Mycobacterium tuberculosis by Real-Time PCR Based on Taqman and HRM Assays
by: Samira Sheikh Ghomi, et al.
Published: (2014-06-01)

Evaluation of the frequency of resistance to 2 drugs (Isoniazid and Rifampin) by molecular investigation and it's risk factors in new cases of smear positive pulmonary tuberculosis in health centers under the cover of Jundishapur University of Medical Sciences in 2017
by: Shokrollah Salmanzadeh, et al.
Published: (2020-01-01)

Detection of genomic mutations in katG and rpoB genes among multidrug-resistant Mycobacterium tuberculosis isolates from Tehran, Iran
by: B. Motavaf, et al.
Published: (2021-05-01)

Nanostructured Dihydroartemisinin Plus Epirubicin Liposomes Enhance Treatment Efficacy of Breast Cancer by Inducing Autophagy and Apoptosis
by: Ying-Jie Hu, et al.
Published: (2018-10-01)